ChoA Pharmaceutical (034940)

KOSDAQ · 550 KRW · As of Aug 26, 2026 close

1Y Close · As of Aug 26, 2026

Mkt Cap

17.0B

Rev (2025)

59.3B

Op Inc (2025)

-6.6B

Net Inc (2025)

-7.4B

PBR

0.78

52W

0K~1K

ChoA Pharmaceutical operates in the Pharmaceuticals sector.

Legal name: ChoA Pharmaceutical Co., LTD.

In fiscal year 2025, ChoA Pharmaceutical (034940) reported revenue of 59.3 billion KRW, down 5.4% from 62.7 billion KRW a year earlier.

Operating profit was -6.6 billion KRW and net income was -7.4 billion KRW in the same year.

As of the Aug 26, 2026 close, the market capitalization was 17.0 billion KRW, with a P/B of 0.78.

These figures can be verified in the DART filing (receipt no. 20260313000763).

Year	Rev	Op Inc	Net Inc
2025	59.3B	-6.6B	-7.4B
2024	62.7B	-9.6B	-10.2B
2023	63.0B	-6.8B	-11.1B

3 applicable out of 8 items

Trading Halt Lifted (Reverse Split Re-listing)

Semi-Annual Report (2026.06)

Trading Halt (Share Consolidation/Split Electronic Change)

Checks

3 of 8 checked items currently applicable.

Market Cap & Price: Market cap is below the delisting threshold for 20 consecutive days.

Administrative Designation: 1 administrative designation criteria met. [source]

Audit Opinion: Audit opinion: Unqualified (clean).

Convertible Bonds: No convertible bonds outstanding.

Capital Increase: No capital-increase filings in the last 180 days.

Treasury Stock: No treasury stock filings.

Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.

Major Shareholder Change: No major shareholder changes in the last 180 days.

Market Action: 2 market action(s) (trading halt, delisting, etc.) recorded. [source]

These checks are mechanical tests of disclosed figures and do not constitute investment advice or recommendations.

Date	Filing
2026-08-26	Trading Halt Lifted (Reverse Split Re-listing)
2026-08-14	Semi-Annual Report (2026.06)
2026-07-31	Trading Halt (Share Consolidation/Split Electronic Change)